Why Archer-Daniels-Midland (ADM) is back in focus

Archer-Daniels-Midland (ADM) is back on many watchlists after an accounting investigation, a new CEO appointment, a push into higher-margin food and bio-based products, and fourth-quarter 2025 earnings that exceeded analyst expectations on adjusted EPS.

ADM shares have been climbing steadily, with a 90 day share price return of 15.42% and a 1 year total shareholder return of 54.71%. This suggests momentum has picked up as the accounting review, leadership change, and recent earnings beat stay front of mind for investors.

If this rebound in an established agribusiness has your attention, it could be a good moment to broaden your search and check out 19 top founder-led companies as potential long term compounders.

With ADM trading at US$69.61, above an average analyst price target of US$60.73 yet showing an estimated 16.11% intrinsic discount, you have to ask yourself: is there still a buying opportunity here, or is future growth already priced in?

Most Popular Narrative: 14.6% Overvalued

Simply Wall St’s most followed narrative pegs Archer-Daniels-Midland’s fair value at $60.73, below the last close of $69.61. This sets up an interesting tension with the recent share price strength.

Growth in the Nutrition segment, driven by geographic expansion, innovation in probiotics and flavors, and the shift to higher-margin specialty and health ingredients, aligns with changing consumer preferences for processed and convenience foods, providing ADM with a path to higher revenue growth and greater margin stability.

Curious what kind of revenue growth path and margin rebuild are baked into that fair value, and how long it takes to play out? The narrative leans on a specific profit profile, a defined earnings step up and a future P/E that looks more conservative than many investors might assume.

Result: Fair Value of $60.73 (OVERVALUED)

However, there is still the risk that weaker margins in core Ag Services & Oilseeds, or ongoing biofuel policy uncertainty, could disrupt that fair value path.

Another View: Cash Flows Tell a Different Story

While one common view suggests Archer-Daniels-Midland is 14.6% overvalued, with a fair value estimate of $60.73, our DCF model suggests a fair value of $82.98, indicating the shares are trading at a 16.1% discount. This raises a key question: which set of assumptions seems more reliable, the earnings multiple path or the cash flow path?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Archer-Daniels-Midland for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 45 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of risks and potential rewards leaves you unsure, take a closer look now and review the full picture with 2 key rewards and 4 important warning signs.

Looking for more investment ideas?

If ADM has you rethinking your watchlist, do not stop here. Use the broader market to pressure test your thesis and spot fresh opportunities.

• Target dependable cash generators by scanning companies that look attractively priced with 45 high quality undervalued stocks built straight from their fundamentals.
• Prioritise staying power by focusing on businesses screened for resilience using our 76 resilient stocks with low risk scores to help you avoid fragile balance sheets.
• Hunt for tomorrow’s potential standouts early with a curated screener containing 24 high quality undiscovered gems that most investors may not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.